Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 3
1999 1
2000 1
2002 2
2003 3
2004 1
2005 1
2006 4
2007 1
2008 3
2009 7
2010 1
2011 3
2012 3
2013 1
2014 4
2016 4
2017 3
2018 7
2019 9
2020 10
2021 4
2022 4
2023 2
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.
Zabel M, Willems R, Lubinski A, Bauer A, Brugada J, Conen D, Flevari P, Hasenfuß G, Svetlosak M, Huikuri HV, Malik M, Pavlović N, Schmidt G, Sritharan R, Schlögl S, Szavits-Nossan J, Traykov V, Tuinenburg AE, Willich SN, Harden M, Friede T, Svendsen JH, Sticherling C, Merkely B; EU-CERT-ICD Study Investigators. Zabel M, et al. Among authors: flevari p. Eur Heart J. 2020 Sep 21;41(36):3437-3447. doi: 10.1093/eurheartj/ehaa226. Eur Heart J. 2020. PMID: 32372094 Free PMC article.
Performance of Different Risk Scores for the Detection of Atrial Fibrillation Among Patients With Cryptogenic Stroke.
Palaiodimou L, Theodorou A, Triantafyllou S, Dilaveris P, Flevari P, Giannopoulos G, Kossyvakis C, Adreanides E, Tympas K, Nikolopoulos P, Zompola C, Bakola E, Chondrogianni M, Magiorkinis G, Deftereos S, Giannopoulos S, Tsioufis K, Filippatos G, Tsivgoulis G. Palaiodimou L, et al. Among authors: flevari p. Stroke. 2024 Feb;55(2):454-462. doi: 10.1161/STROKEAHA.123.044961. Epub 2024 Jan 4. Stroke. 2024. PMID: 38174570
Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project.
Zabel M, Schlögl S, Lubinski A, Svendsen JH, Bauer A, Arbelo E, Brusich S, Conen D, Cygankiewicz I, Dommasch M, Flevari P, Galuszka J, Hansen J, Hasenfuß G, Hatala R, Huikuri HV, Kenttä T, Kucejko T, Haarmann H, Harden M, Iovev S, Kääb S, Kaliska G, Katsimardos A, Kasprzak JD, Qavoq D, Lüthje L, Malik M, Novotný T, Pavlović N, Perge P, Röver C, Schmidt G, Shalganov T, Sritharan R, Svetlosak M, Sallo Z, Szavits-Nossan J, Traykov V, Vandenberk B, Velchev V, Vos MA, Willich SN, Friede T, Willems R, Merkely B, Sticherling C; EU-CERT-ICD Study Investigators. Zabel M, et al. Among authors: flevari p. J Electrocardiol. 2019 Nov-Dec;57S:S34-S39. doi: 10.1016/j.jelectrocard.2019.09.001. Epub 2019 Sep 4. J Electrocardiol. 2019. PMID: 31526572 Review.
Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society.
Chrysohoou C, Aggeli C, Avgeropoulou C, Aroni M, Bonou M, Boutsikou M, Brili S, Chamodraka E, Dagre A, Flevari P, Fountoulaki A, Frogoudaki A, Gkouziouta A, Grapsa J, Hatzinikolaou-Kotsakou E, Kalantzi K, Kitsiou A, Kostakou P, Kourea R, Koutrolou-Sotiropoulou P, Marketou M, Mavrogeni S, Naka KK, Nikolaou M, Papazachou O, Papavasileiou LP, Simeonidou E, Theopistou A, Triantafyllidi H, Trikka C, Tsekoura D, Tzifa A, Vaina S, Vrettou AR, Zaglavara T, Kolovou G; Reviewers. Chrysohoou C, et al. Among authors: flevari p. Hellenic J Cardiol. 2020 Nov-Dec;61(6):362-377. doi: 10.1016/j.hjc.2020.09.015. Epub 2020 Oct 9. Hellenic J Cardiol. 2020. PMID: 33045394 Free PMC article. Review.
Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?
Komninaka V, Flevari P, Karkaletsis G, Androutsakos T, Karkaletsi T, Ntanasis-Stathopoulos I, Ntelaki EE, Terpos E. Komninaka V, et al. Among authors: flevari p. Diseases. 2023 Nov 6;11(4):161. doi: 10.3390/diseases11040161. Diseases. 2023. PMID: 37987272 Free PMC article.
77 results